A detailed history of Mayo Clinic transactions in Zentalis Pharmaceuticals, Inc. stock. As of the latest transaction made, Mayo Clinic holds 175,000 shares of ZNTL stock, worth $565,250. This represents 23.63% of its overall portfolio holdings.

Number of Shares
175,000
Previous 187,143 6.49%
Holding current value
$565,250
Previous $765,000 16.08%
% of portfolio
23.63%
Previous 26.74%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$2.9 - $4.57 $35,214 - $55,493
-12,143 Reduced 6.49%
175,000 $642,000
Q2 2023

Aug 09, 2023

SELL
$17.41 - $30.05 $1.92 Million - $3.31 Million
-110,000 Reduced 37.02%
187,143 $5.28 Million
Q4 2022

Jan 26, 2023

SELL
$18.07 - $25.6 $999,560 - $1.42 Million
-55,316 Reduced 15.69%
297,143 $5.98 Billion
Q2 2021

Aug 12, 2021

SELL
$37.41 - $62.25 $374,099 - $622,500
-10,000 Reduced 2.76%
352,459 $18.8 Million
Q4 2020

Feb 11, 2021

SELL
$31.71 - $57.97 $2.54 Million - $4.65 Million
-80,255 Reduced 18.13%
362,459 $18.8 Million
Q3 2020

Nov 12, 2020

BUY
$27.03 - $47.97 $27 - $47
1 Added 0.0%
442,714 $14.5 Million
Q2 2020

Aug 13, 2020

BUY
$23.2 - $54.8 $10.3 Million - $24.3 Million
442,713 New
442,713 $21.3 Million

Others Institutions Holding ZNTL

About Zentalis Pharmaceuticals, Inc.


  • Ticker ZNTL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 56,983,600
  • Market Cap $184M
  • Description
  • Zentalis Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule therapeutics for the treatment of various cancers. Its lead product candidate includes the ZN-c3, an inhibitor of WEE1, a protein tyrosine kinase, which is in Phase 2 clinical trial for the treatment of advanced solid ...
More about ZNTL
Track This Portfolio

Track Mayo Clinic Portfolio

Follow Mayo Clinic and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mayo Clinic, based on Form 13F filings with the SEC.

News

Stay updated on Mayo Clinic with notifications on news.